Results 241 to 250 of about 3,437,924 (390)

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk   +12 more
wiley   +1 more source

Artificial intelligence-enhanced electrocardiography and sudden death risk factors in cardiac arrest survivors diagnosed with hypertrophic cardiomyopathy. [PDF]

open access: yesHeart Rhythm O2
Swain WH   +12 more
europepmc   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

Current causes of sudden death in large populations: differences between resuscitated patients and autopsied cases. [PDF]

open access: yesEur Heart J Open
Marimpouy N   +15 more
europepmc   +1 more source

[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].

open access: yesKardiologia polska, 2015
S. Priori   +17 more
semanticscholar   +1 more source

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao   +27 more
wiley   +1 more source

Sudden Unexplained Nocturnal Death Syndrome: The Hundred Years' Enigma

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Jingjing Zheng   +3 more
doaj   +1 more source

Sudden Death Induced by Acute Inhalation of Aerosolized Carfentanil. [PDF]

open access: yesArch Clin Biomed Res
Gao X, Zhuang J, Chen Z, Shi S, Xu F.
europepmc   +1 more source

Home - About - Disclaimer - Privacy